Crinetics Pharmaceuticals, Inc.
CRNX
Kedudukan dalam Saham
#2241
Crinetics Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical... Crinetics Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical enterprise, dedicated to the identification, advancement, and market introduction of therapeutic solutions for infrequent endocrine conditions and related tumors. Their flagship drug candidate, Paltusotine, is an orally administered, selective, non-peptide somatostatin receptor type 2 agonist. This compound has concluded its Phase III clinical trials for the treatment of acromegaly, and has also completed Phase II trials targeting carcinoid syndrome and nonfunctional neuroendocrine tumors (NETs). Furthermore, the company's pipeline includes CRN04777, an oral selective non-peptide somatostatin type 5 receptor agonist, which is currently undergoing Phase I clinical trials for congenital hyperinsulinism. Another investigational drug, CRN04894, an oral adrenocorticotrophic hormone antagonist, is in Phase I clinical trials for Cushing's disease and congenital adrenal hyperplasia. Crinetics Pharmaceuticals, Inc. was founded in 2008 and maintains its headquarters in San Diego, California.
Harga Saham
$84.95
Disegerakkan terakhir: 2026-09-01
Modal Pasaran
$9.00B
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
104.35%
Negara
US
Perdagangan Crinetics Pharmaceuticals, Inc. (CRNX)
Kategori
Healthcare
Margin Operasi untuk Crinetics Pharmaceuticals, Inc. (CRNX)
Margin Operasi pada October 2026 TTM: -1,302.52%
Menurut laporan kewangan dan harga saham terkini Crinetics Pharmaceuticals, Inc., margin operasi semasa (TTM) ialah -1,302.52%. Pada akhir 2023, margin operasi syarikat ialah -5,547.17%.
Sejarah Margin Operasi untuk Crinetics Pharmaceuticals, Inc. dari 2016 hingga 2026
Margin Operasi pada akhir setiap tahun
| Tahun | Margin Operasi | Ubah |
|---|---|---|
| 2026 (TTM) | -1,302.52% | -96.01% |
| 2024 | -32,613.47% | 487.93% |
| 2023 | -5,547.17% | 56.52% |
| 2022 | -3,544.06% | -64.53% |
| 2021 | -9,990.91% | -90.54% |
| 2020 | -105,567.61% | 2,239.54% |
| 2019 | -4,512.32% | 281.61% |
| 2018 | -1,182.45% | 164.94% |
| 2017 | -446.31% | -56.51% |
| 2016 | -1,026.15% | 0.00% |
Margin Operasi untuk syarikat serupa atau pesaing
| Syarikat | Margin Operasi | Perbezaan Margin Operasi | Negara |
|---|---|---|---|
| 38.59% | -100.03% |
US
|
|
| -149.01% | -99.89% |
US
|
|
| 25.57% | -100.02% |
AU
|
|
| 0.00% | - |
CH
|
|
| 28.81% | -100.02% |
NL
|
Apakah Margin Operasi sesebuah syarikat?
Margin Operasi ialah penunjuk utama untuk menilai keuntungan sesebuah syarikat. Margin Operasi yang lebih tinggi lazimnya lebih baik kerana menunjukkan bahawa syarikat mampu menjual produk atau perkhidmatannya dengan harga yang jauh lebih tinggi daripada kos pengeluarannya. Ia dikira dengan membahagikan keuntungan syarikat dengan hasilnya.